enGene Therapeutics Inc.
Biological Products, (No Diagnostic Substances) | SIC: 2836Phone: (514) 332-4888
State of Inc.: Z4
- Nasdaq:ENGN
- Nasdaq:ENGNW
Form: 10-Q
Filing Date: 15 Jun 2026Report Date: 30 Apr 2026
Accepted: 15 Jun 2026 07:16 a.m.
Accession Number: 0001193125-26-270386
File Number: 001-41854
Film Number: 261089205
Documents
Primary Document: 10-Q
Accepted: 15 Jun 2026 07:16 a.m.
0001193125-26-270386-index-headers.html
Last Modified: 15 Jun 2026 07:16 a.m.
0001193125-26-270386-index.html
Last Modified: 15 Jun 2026 07:16 a.m.
0001193125-26-270386.txt
Last Modified: 15 Jun 2026 07:16 a.m.
0001193125-26-270386-xbrl.zip
Last Modified: 15 Jun 2026 07:16 a.m.
engn-20260430.xsd
Last Modified: 15 Jun 2026 07:16 a.m.
engn-20260430_htm.xml
Last Modified: 15 Jun 2026 07:16 a.m.
engn-ex10_2.htm
Last Modified: 15 Jun 2026 07:16 a.m.
engn-ex10_3.htm
Last Modified: 15 Jun 2026 07:16 a.m.
engn-ex31_1.htm
Last Modified: 15 Jun 2026 07:16 a.m.
engn-ex31_2.htm
Last Modified: 15 Jun 2026 07:16 a.m.
engn-ex32_1.htm
Last Modified: 15 Jun 2026 07:16 a.m.
engn-ex32_2.htm
Last Modified: 15 Jun 2026 07:16 a.m.
FilingSummary.xml
Last Modified: 15 Jun 2026 07:16 a.m.
MetaLinks.json
Last Modified: 15 Jun 2026 07:16 a.m.
R1.htm
Last Modified: 15 Jun 2026 07:16 a.m.
R10.htm
Last Modified: 15 Jun 2026 07:16 a.m.
R11.htm
Last Modified: 15 Jun 2026 07:16 a.m.
R12.htm
Last Modified: 15 Jun 2026 07:16 a.m.
R13.htm
Last Modified: 15 Jun 2026 07:16 a.m.
R14.htm
Last Modified: 15 Jun 2026 07:16 a.m.
R15.htm
Last Modified: 15 Jun 2026 07:16 a.m.
R16.htm
Last Modified: 15 Jun 2026 07:16 a.m.
R17.htm
Last Modified: 15 Jun 2026 07:16 a.m.
R18.htm
Last Modified: 15 Jun 2026 07:16 a.m.